top of page
![origenis_logo_Pantone [Konvertiert]_2020](https://static.wixstatic.com/media/9afeac_83ea95f8f63144538d48a310b96d7f33~mv2.png/v1/fill/w_260,h_53,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/origenis_logo_Pantone%20%5BKonvertiert%5D_2020.png){kind=logo}
Press releases
Reaching new heights
Press releases
Reaching new heights
-
25. Jan. 20192 Min. Lesezeit
Origenis GmbH Announces Global License and Collaboration Agreement with Expansion Therapeutics . . .
January 25, 2019 Origenis GmbH Announces Global License and Collaboration Agreement with Expansion Therapeutics for Novel Therapies...
257
-
22. März 20181 Min. Lesezeit
Origenis Appoints Dr. Peter Seufer-Wasserthal as Chief Business Officer
March 22, 2018 Origenis GmbH, a Germanbiotech company specializing in the discovery and development of highly selective small...
174
-
23. Mai 20171 Min. Lesezeit
Origenis Announces Patent Grants for Lead Small Molecule LRRK2 Inhibitors for Treatment . . .
May 23, 2017 Worldwide DistributionOrigenis Announces Patent Grants for Lead Small Molecule LRRK2 Inhibitors for Treatment of...
177
bottom of page